Skip to content

Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke

Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00478478
Enrollment
1000
Registered
2007-05-24
Start date
2007-06-30
Completion date
2010-09-30
Last updated
2014-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Stroke, Ischemic, Thrombus, Embolectomy, Thrombectomy, Merci, Concentric, Embolus, Embolism, Mechanical

Brief summary

Post-Market Registry on Use of Merci Retrieval System. Primary data to be collected will include: * Post-procedure revascularization success * 90-day mRS 0-2 * 90-day mortality

Detailed description

The Merci Registry is a prospective multicenter registry with up to 3000 patients enrolled at a maximum of 100 sites. The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.

Interventions

PROCEDUREMechanical Thrombectomy

Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.

Sponsors

Stryker Neurovascular
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient with ischemic stroke is treated with a Merci Retriever that is indicated for thrombus removal in ischemic stroke. Treated is defined as being when a Merci Retriever is deployed in the neurovasculature of a patient with an ischemic stroke * Patient/patient's surrogate provides informed consent and is willing to comply with the protocol requirements and complete required clinical evaluations, or in the absence of informed consent, an IRB/EC approved waiver of consent and executed data use agreement are in place

Exclusion criteria

-There are no

Design outcomes

Primary

MeasureTime frame
Post-procedure revascularization successpost-procedure

Secondary

MeasureTime frame
NIHSS change from baseline to 24-hours24-hour
90-day mRS outcomes90-day
90-day mortality90-day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026